We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+3.48%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$36.8B
AUM Growth
-$1.51B
Cap. Flow
-$2.66B
Cap. Flow %
-7.22%
Top 10 Hldgs %
39.58%
Holding
603
New
45
Increased
143
Reduced
276
Closed
116

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$400M
2
BBBY
Bed Bath & Beyond Inc
BBBY
+$263M
3
JPM icon
JPMorgan Chase
JPM
+$197M
4
CVX icon
Chevron
CVX
+$182M
5
COP icon
ConocoPhillips
COP
+$176M

Top Sells

Rank Stock Value
1
CSCO icon
Cisco
CSCO
+$366M
2
JNJ icon
Johnson & Johnson
JNJ
+$331M
3
IBM icon
IBM
IBM
+$284M
4
PG icon
Procter & Gamble
PG
+$239M
5
PEP icon
PepsiCo
PEP
+$208M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Healthcare 19.45%
3 Consumer Staples 17.77%
4 Energy 8.18%
5 Consumer Discretionary 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
26
Medtronic
MDT
$107B
$352M 0.96%
5,518,126
-1,532,333
-22% -$93.1M
EMC
27
DELISTED
EMC CORPORATION
EMC
$344M 0.93%
13,058,932
-522,200
-4% -$13.8M
EEM icon
28
iShares MSCI Emerging Markets ETF
EEM
$28B
$335M 0.91%
7,739,700
+3,451,965
+81% +$147M
MON
29
DELISTED
Monsanto Co
MON
$330M 0.9%
2,644,956
+533,000
+25% +$62.4M
ACN icon
30
Accenture
ACN
$89.9B
$312M 0.85%
3,865,477
+180,900
+5% +$14.5M
EBAY icon
31
eBay
EBAY
$48.6B
$306M 0.83%
14,533,733
+593,762
+4% +$12.9M
EMR icon
32
Emerson Electric
EMR
$82.9B
$306M 0.83%
4,611,360
-291,500
-6% -$19.6M
NKE icon
33
Nike
NKE
$61.9B
$298M 0.81%
7,679,180
-780,950
-9% -$29M
DHR icon
34
Danaher
DHR
$135B
$275M 0.75%
5,198,518
+187,616
+4% +$9.64M
COP icon
35
ConocoPhillips
COP
$147B
$273M 0.74%
3,180,340
+2,255,300
+244% +$176M
BIIB icon
36
Biogen
BIIB
$29.9B
$270M 0.73%
857,799
+380,800
+80% +$115M
LLY icon
37
Eli Lilly
LLY
$1.07T
$254M 0.69%
4,083,353
-1,027,371
-20% -$61.3M
COV
38
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$250M 0.68%
2,776,488
+672,900
+32% +$50.3M
BAX icon
39
Baxter International
BAX
$11.6B
$246M 0.67%
6,255,258
-227,558
-4% -$9.1M
COST icon
40
Costco
COST
$415B
$217M 0.59%
1,880,088
+40,300
+2% +$4.62M
MA icon
41
Mastercard
MA
$477B
$209M 0.57%
2,849,418
+845,197
+42% +$62.8M
ITW icon
42
Illinois Tool Works
ITW
$81.4B
$196M 0.53%
2,243,634
-27,900
-1% -$2.4M
SYK icon
43
Stryker
SYK
$127B
$173M 0.47%
2,047,202
-425,500
-17% -$34.7M
PCP
44
DELISTED
PRECISION CASTPARTS CORP
PCP
$172M 0.47%
679,582
+95,800
+16% +$24.5M
BDX icon
45
Becton Dickinson
BDX
$43.1B
$169M 0.46%
1,467,388
-195,160
-12% -$22.1M
AGN
46
DELISTED
Allergan Inc
AGN
$165M 0.45%
973,051
-128,700
-12% -$20M
ELV icon
47
Elevance Health
ELV
$81.9B
$161M 0.44%
1,492,766
-488,800
-25% -$50.4M
CTSH icon
48
Cognizant
CTSH
$21.5B
$158M 0.43%
3,230,350
+260,640
+9% +$12.7M
OXY icon
49
Occidental Petroleum
OXY
$57B
$156M 0.42%
1,584,134
+932,833
+143% +$87.7M
CHKP icon
50
Check Point Software Technologies
CHKP
$13.3B
$148M 0.4%
2,210,400
+1,733,600
+364% +$114M
1
2
3 4 5

Similar funds

Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2014 Portfolio in Review

As of Q2 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 603 positions worth $36.8B, down 4% from $38.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.66B in Q2 2014, closing 116 positions and reducing 276 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in SAFEWAY INC worth $37.3M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2014 buy was SAFEWAY INC: 1,085,800 shares worth $37.3M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Express Scripts Holding Company in Q2 2014, an estimated $400M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2014 reduction was Cisco, cutting an estimated $366M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Vanguard FTSE Emerging Markets ETF in Q2 2014, selling an estimated $76M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $36.8B portfolio in Q2 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 45 new positions and closed 116 in Q2 2014.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 4% quarter-over-quarter to $36.8B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2014, filed 13 Aug 2014.